CS logo
small CS logo
Kuopio University Hospital Cancer Center

Kuopio, Finland
Hospital in Kuopio
Puijonlaaksontie 2, 70210 Kuopio

About Kuopio University Hospital Cancer Center


Kuopio University Hospital is a teaching hospital of the University of Eastern Finland along Puijonlaaksontie at the Puijonlaakso district in Kuopio, Finland.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Genmab
1
Scandinavian Sarcoma Group
1
Total Rows: 2

Clinical Trials at Kuopio University Hospital Cancer Center


During the past decade, Kuopio University Hospital Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails202100.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib
2012-02-01
2016-11-01
Completed
72
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in R/R DLBCL
2021-01-13
2024-05-01
Recruiting
480

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Kuopio University Hospital Cancer Center" #1 collaborator was "AbbVie" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGenmab: 1Genmab: 1Scandinavian Sarcoma Group: 1Scandinavian Sarcoma Group: 1

Created with Highcharts 11.1.0Top CollaboratorsAbbVie: 1AbbVie: 1GlaxoSmithKline: 1GlaxoSmithKline: 1

Clinical Trials Conditions at Kuopio University Hospital Cancer Center


According to Clinical.Site data, the most researched conditions in "Kuopio University Hospital Cancer Center" are "Diffuse Large B-cell Lymphoma" (1 trials) and "Gastrointestinal Stromal Tumors" (1 trials). Many other conditions were trialed in "Kuopio University Hospital Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Kuopio University Hospital Cancer Center


Most popular intervention types in "Kuopio University Hospital Cancer Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Epcoritamab" (1 trials), "Investigator's Choice Chemotherapy" (1 trials) and "Pazopanib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kuopio University Hospital Cancer Center


The vast majority of trials in "Kuopio University Hospital Cancer Center" are 2 trials for "All" genders.

Clinical Trials Status at Kuopio University Hospital Cancer Center


Currently, there are NaN active trials in "Kuopio University Hospital Cancer Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kuopio University Hospital Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kuopio University Hospital Cancer Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 1Phase 2: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 1Completed: 1Recruiting: 1Recruiting: 1